June 11, 2025
mayank
ICICI Prudential Nifty Pharma Index Fund details, NAV, Portfolio, Returns, Peer Comparison, Fund Managers & Guidance by sahifund.com
NAV Growth: Rs 16.9249
NAV IDCW: Rs 16.9258
Suitable For Which Investors?
This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.
We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in flexi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.
But if you do invest, you must do so only through the SIP route.
Fund’s Investment Strategy:
The Scheme seeks to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index
Fund Manager:
1) Ashwini Shinde
Education: B.Com , M.Com , Inter CA
Experience: Prior to Joining the ICICI Pru Mutual Fund he has worked with ICICI Pru AMC Treasury Mutual Fund Operations,
2) Nishit Patel
Education: Mr. Patel is a B.Com & Chartered Accountant
Experience: Prior to joining ICICI Prudential Mutual fund, he has worked with K.K.Dand & Co.
Investment Details
| Min. Investment (Rs) | 1,000 |
| Min. Addl Investment (Rs) | 1,000 |
| Min. SIP Investment (Rs) | 1,000 |
| Min. Withdrawal (Rs) | — |
| Min. No of Cheques | 6 |
| Min. Balance (Rs) | — |
| Lock-in Period | NA |
| Exit Load | 0 |
Basic Details of ICICI Prudential Nifty Pharma Index Fund
| Fund House | ICICI Prudential Mutual Fund |
| Launch Date | 14-Dec-22 |
| Return Since Launch | 23.53% |
| Benchmark | NIFTY Pharma TRI |
| Riskometer | Very High |
| Type | Open-ended |
| Assets | Rs 84 Cr |
| (As on 31-May-2025) | |
| Expense | 0.37% |
| (As on 31-May-2025) | |
| Risk Grade | — |
| Return Grade | — |
| Turnover | 71.00% |
Trailing Returns (%) of ICICI Prudential Nifty Pharma Index Fund
| Fund name | YTD | 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | 7Y | 10Y |
| ICICI Pru Nifty Pharma Index Dir | -6.12 | 0.55 | 4.11 | 8.27 | -1.43 | 11.16 | — | — | — | — |
| BSE Healthcare TRI | -3.33 | 0.45 | 5.99 | 11.51 | -1.20 | 20.07 | — | — | — | — |
| Equity: Sectoral-Pharma | -3.92 | 0.40 | 5.48 | 9.82 | -1.88 | 18.09 | — | — | — | — |
| Rank within category | 18 | 5 | 20 | 18 | 9 | 15 | — | — | — | — |
| Number of funds in category | 21 | 21 | 21 | 21 | 19 | 17 | 11 | 9 | 4 | 3 |
Peer Comparison of ICICI Prudential Nifty Pharma Index Fund
| Rating | 1 Year Returns | 3 Year Returns | 5 Year Returns | Expense Ratio (%) | Net Assets (Rs Cr) | Return Since Launch (%) | Exit Load (Days) | Fund Age | Turnover (%) | |
| ICICI Pru Nifty Pharma Index Dir | Unrated | 11.16 | — | — | 0.37 | 84 | 23.53 | — | 2Y 5M | 71.00 |
| Nippon India Nifty Pharma ETF | Unrated | 11.41 | 21.48 | — | 0.21 | 968 | 11.58 | — | 3Y 11M | 45.00 |
| ICICI Pru Pharma Healthcare and Diagnostics Dir | 4 star | 24.38 | 30.02 | 25.93 | 1.06 | 5,508 | 23.21 | 1.00 (15) | 6Y 10M | 81.00 |
| SBI Healthcare Opportunities Dir | 5 star | 22.01 | 29.66 | 25.06 | 0.90 | 3,689 | 18.30 | 0.50 (15) | 12Y 5M | 24.00 |
| DSP Healthcare Dir | 4 star | 17.95 | 27.30 | 24.91 | 0.62 | 2,912 | 24.79 | 0.50 (30) | 6Y 6M | 22.00 |
Portfolio Analysis of ICICI Prudential Nifty Pharma Index Fund
| No. of Stocks | 20 |
| Top 10 Stocks | 80.66% |
| Top 5 Stocks | 61.76% |
| Top 3 Sectors | 99.90% |
| Portfolio P/B Ratio | 4.94 |
| Portfolio P/E Ratio | 32.55 |
Portfolio Breakup
| Fund | Category | |
| Average Mkt Cap (Rs Cr) | 1,17,618 | 85,475 |
| Giant (%) | 34.76 | 25.07 |
| Large (%) | 42.33 | 36.23 |
| Mid (%) | 21.89 | 31.85 |
| Small (%) | 1.01 | 8.73 |
| Tiny (%) | — | 0.08 |
Chanakya’s Mutual Fund Guidance For ICICI Prudential Nifty Pharma Index Fund
WILL Post Soon
Disclaimer: Mutual fund investments are subject to market risks. Read all scheme related documents carefully
Apply Online: https://www.icicipruamc.com/sign-in
>> Post your MF questions @ sahifund.com/ask-me/
>> NFO Guidance:
https://sahifund.com/category/nfos/
Quicklinks